Über das Unternehmen
- Firmenname (rechtlich): Guangdong Raffles PharmaTech Co Ltd
- Registrierungsland: China
- Adresse: No 3, Binhai 10th Road North, Shihua Dadao Middle, Daya Bay, Huizhou, Guangdong
- Anzahl der Mitarbeiter: 250 - 499
Beschreibung:
Established in August 2011, Raffles PharmaTech is a high-tech enterprise that focus on development, manufacturing and sales of high-value added active pharmaceutical ingredients and intermediates. We are specialized in applying organic catalysts into the process development to lower cost, and to provide cost-effective product and service to customers. With our strong R&D capability and our proprietary organic catalysts, we provide low cost and high quality active pharmaceutical ingredients and intermediates to pharmaceutical companies. We also provide world standard process development, custom synthesis and manufacturing service.
Geschäftsaktivitäten
Pharmazeutische Wirkstoffe (API)
Hersteller
Vertrags- & Outsourcing-Dienstleistungen
Hersteller
Pharmazeutische Chemikalien
Hersteller
Auftragsforschungsdienstleistungen (CRO)
Hersteller
Biopharmazeutische Dienstleistungen
Hersteller
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
Hauptprodukte/-dienstleistungen
- Pharmazeutische Chemikalien: (2R,6R)-2,6-diphenyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2R)-2-Piperidine Methanamine, (3S,11aR)-N-(2,4-difluorobenzyl)-6-methoxy-3-methyl-5,7, (3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-benzyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-tert-butyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole, (2S,6S)-2,6-Di-iso-propyl-2,3,5,6-tetrahydro-1H-imidazo[1,2-a]imidazole HI salt, 1,5,7-Triazabicyclo[4.4.0]dec-5-ene, 1,4,6-Triazabicyclo[3.3.0]oct-4-ene, (4S,5S)-1H-lmidazolium,2- [[(4S,5S)-1,3-dimiethyl-4,5, (S)-a-(Phenylmethyl)-1-pyrrolidinethanamine, (R)-VAPOL HYDROGENPHOSPHATE, (8a,9R)- 10,11-dihydro-Cinchonan-6',9-diol, (9S)-9-(9-phenanthrenyloxy)-Cinchonan-6'-ol, (S)-(–)-a,a-Diphenyl-2-pyrrolidinemethanol trimethylsilyl ether, 2-(diphenylphosphino)-N-(pyridin-2-ylmethyl)ethanamine, (S)-5-Benzyl-2-mesityl-6,6-dimethyl-6,8-dihydro-5H- [1,2,4], (5aR,10bS)-(+)-5a,10b-Dihydro-2-(pentafluorophenyl, (5aS, 10bR)-(-)-5a,10b-Dihydro-2-(pentafluorophe, 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene, (S)-5-benzyl-2-phenyl-6,8-dihydro-5H-[1,2,4]triazolo[3,4-c], (S)-2-[[(1R,2R)-2-AMINOCYCLOHEXYL]THIOUREIDO] -N-BENZYL-N,3,3-TRIMETHYLBUTANAMIDE, (2S)-2-[[[[3,5-Bis(trifluoromethyl) phenyl]amino], 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea, (2S)-2-amino-N,3,3-trimethyl-N-(phenylmethyl)-ButaN/Amide, (S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl) -3-((1R,2R)-2-(dipropylamino)cyclohexyl)thiour, 1-[3,5-Bis(trifluoromethyl)phenyl]-3- [(1S,2S)-2-(dimethylamino)cyclohexyl]thiourea, (S)-2-[[(1R,2R)-2-[[[3,5-Bis(tert-butyl)-2-hydroxyphenyl] methylene]amino]cyclohexyl]thioureido], 2-Propanesulfinamide, N-[(1R,2R)-2-[[[[3,5-bis(trifluoromethyl)phenyl]amino] carbonyl]amino]cycloh, (2S)-3,3-DIMETHYL-2-[[(1R,2R)-2-(2-METHYL-5-PHENYL-1-PYRROLYL) CYCLOHEXYL]THIOUREIDO]-N,N-BIS(2-ISO, (R,R)-(+)-Hydrobenzoin, (2S)-2-Piperidine Methanamine, (2S,3S,4S,5R,6R)-6-bromotetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate, (3S)-3-Thiophenamine, tetrahydro-, 1,1-dioxide, hydrochloride (1:1), (2S,3R)-2-hydroxy-3-(naphthalen-2-ylmethyl)succinic acid1, (R)-2-((S)-2,2-dimethyl-5-oxo-1,3-dioxolan-4-yl) -3-(naphthalen-2-yl)propanoic acid, (S)-4-(3,4-Dichlorophenyl)-3,4-dihydro-1-naphthalenone, 1,4-difluoroanthraquinone
Unsere Produkte & Dienstleistungen
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Certifications
GMP
ISO
Proofs
CPHI Milan 2026
10/2026 – 10/2026
CPHI Milan 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen